Immunization with HIV protease peptides linked to syngeneic erythrocytes

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Boberg, Andreas ^a,b   Dominici, Sabrina ^c   Brave, Andreas ^a,b   Hallermalm, Kristian ^a,b   Hinkula, Jorma ^d   Magnani, Mauro ^c   Wahren, Britta ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF URBINO   (Italy)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247871336     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-9     Document Type: Article

References (13)

1. Asjo B, Stavang H, Sorensen B, Baksaas I, Nyhus J, Langeland N: Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy. AIDS Res Hum Retroviruses 2002, 18:1357-1365.
2. Pialoux G, Gahery-Segard H, Sermet S, Poncelet H, Fournier S, Gerard L, Tartar A, Gras-Masse H, Levy JP, Guillet JG: Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. Aids 2001, 15:1239-1249.
3. Sommerfell MA, Nyhus J, Sorensen B: Novel peptide-based HIV-1 immunotherapy. Expert Opin Biol Ther 2004, 4:349-361.
4. Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sallberg M, Ortiz GM, Demarest JF, et al.: Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease Gene. J Virol 2003, 77:6743-6752.
5. Chiarantini L: Vaccination Strategy Using Red Blood Cells as Antigen Delivery System Landes Biosciences; 2003.
6. Dominici S, Laguardia ME. Serafini G, Chiarantini L. Fortini C. Tripiciano A, Brocca-Cofano E, Scoglio A, Caputo A, Fiorelli V, et al.: Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. Vaccine 2003, 21:2073-2081.
7. Chiarantini L, Argnani R, Zucchini S, Stevanato L, Zabardi P, Grossi MP, Magnani M, Manservigi R: Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice. Vaccine 1997, 15:276-280.
8. Chiarantini L, Matteucci D, Pistello M, Mancini U, Mazzetti P, Massi C, Giannecchini S, Lonetti I, Magnani M, Bendinelli M: AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. Clin Diagn Lab Immunol 1998, 5:235-241.
9. Magnani M, Chiarantini L, Mancini U: Preparation and characterization of biotinylated red blood cells. Biotechnol Appl Biochem 1994, 20(Pt 3):335-345.
10. Chiarantini L, Droleskey R, Magnani M, DeLoach JR: In vitro targeting of erythrocytes to cytotoxic T-cells by coupling of Thy-1.2 monoclonal antibody. Biotechnol Appl Biochem 1992, 15:171-184.
11. Chiarantini L, Magnani M: Immobilization of enzymes and protein on red blood cells Towata (NJ): Humana Press; 1996:143-152.
12. Magnani M, Chiarantini L, Vittoria E, Mancini U, Rossi L, Fazi A: Red blood cells as an antigen-delivery system. Biotechnol Appl Biochem 1992, 16:188-194.
13. Boberg A, Sjostrand D, Rollman E, Hinkula J, Zuber B, Wahren B: Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization. Vaccine 2006, 24:4527.